Skip to main content

Remote Job Finders (RJF)

Pressure from the FTC and Pfizer is building around Novo Nordisk’s bid to snatch obesity biotech Metsera. The antitrust watchdog has spotted issues with the structure of Novo’s bid, while its New York-based rival has put more money on the table.
Novo’s Metsera Bid Attracts FTC Scrutiny as Pfizer Matches $10B Offer
Scroll to top